American Journal of Infection Control

Identifying routes of transmission among patients during a Candida auris (C. auris) healthcare-associated outbreak can be challenging, particularly among patients in the Burn Intensive Care Unit (BICU). Between January-November 2022 seven patients in

Infection Prevention and Control (IPC) is broad in scope, encompassing all aspects of the healthcare environment. Infection Preventionists (IPs) are expected to be well-rounded and competent in their role, necessitating a robust orientation program

Our academic medical center currently has three job roles within the infection preventionist (IP) job category: IP associate, IP, and senior IP. There is no clear guidance or checklist for progressing through the job roles or criteria for promotion

To mitigate avoidable patient harm, a proactive risk assessment was conducted during the operationalizing of numerous mass vaccination clinics in the midst of a public health emergency. The COVID-19 vaccination rollout met the criteria for a

Decentralized pre-cleaning and high-level disinfection (HLD) increases manpower hours and risks for inconsistent practices. Strategies to foster consistent practices and efficient workflow when handling contaminated probes at the point of care

Central line-associated bloodstream infections (CLABSIs) represent a severe threat to patients that prolong length of stay and increase morbidity, mortality, and healthcare costs. Beginning in August 2021, our cardiac intensive care unit (CICU)

The Medical Surgical Intensive Care Unit’s (MSICU) patient acuity, complexity, and propensity to deterioration was catalyzed by early 2020 COVID-19 patient admissions. This led to a significant increase in reportable Central Line Associated

Challenging to identify and not easily disinfected, Candida auris (C. auris) is a resistant fungus reported in healthcare outbreaks and exacerbated by the COVID-19 pandemic. An interdisciplinary, multimodal approach may reduce transmission risk. Our

Little is known about infection prevention and control (IPC) program gaps subsequent to the COVID-19 pandemic. The Centers for Disease Control and Prevention (CDC) Infection Prevention and Control Assessment and Response (ICAR) tool is used to assess

Healthcare-acquired infections (HAI) in patients undergoing hematopoietic stem cell transplant (HSCT) are associated with an increased risk of mortality. Increased risks are attributed, in part, to immunosuppression, neutropenia and prolonged use of